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In this issue of Immunity, Andres-Terre et al. (2015) and Nakaya et al. (2015) perform multi-cohort meta-
analyses of immune responses to viruses and vaccines. With increased statistical power and more diverse
sampling populations, their findings promise to be more generally applicable and suggestive of novel mech-
anisms for regulating immunity.A central problem in human immunology
is to understand why some individuals
mount productive immune responses to
vaccines and pathogens and others do
not. The move toward systems immu-
nology stems from the idea that emergent
immune system behaviors, such as coor-
dinated immune responses, can best be
understood by discerning the interactions
between cells, proteins, and genes that
collectively give rise to these responses.
Systems analyses aim to quantify as
many components of the system as
possible in the same sample and apply
high-dimensional data analysis tech-
niques to infer probable relationships be-
tween the components. By doing this
in the context of specific immune re-
sponses, the interactions of cells, pro-
teins, and genes underlying the response
of interest can be understood. Systems
approaches are particularly well suited
for studies in human subjects because
of the significant inter-individual variation
in immune cell frequencies, protein con-
centrations, and transcript abundances.
By correlating measurements across indi-
viduals, their probable relationships can
be inferred and the regulation of the
system as a whole investigated (Brodin
et al., 2015). One implication thereof is
that these systems immunology analyses
can prove more informative when per-
formed in heterogeneous populations
than in more homogenous populations.
In these early days of systems immu-
nology, whole blood or blood mononu-
clear cell gene expression analysis has
been the most widely used technology.
It provides a powerful yet convenient
way to globally profile blood immune sys-
tems in humans. The generated blood
transcriptome data represent a compos-
ite measure of genes expressed within
cells and relative frequencies of differentcell populations in the blood (Whitney
et al., 2003). By analyzing modules of
genes rather than individual genes and
by relating the genes within modules to
known cellular pathways and biological
functions, the gene signatures identified
can become more interpretable (Subra-
manian et al., 2005).
In systems immunology as in systems
biology in general, the ability to perturb
the system is key for inferring functional
relationships between system compo-
nents. Vaccination represents the most
widely used immune perturbation in
humans and several recent studies have
utilized systems immunology analyses
before and after vaccination to under-
stand immune responses to vaccines.
Gene expression signatures predictive
of either cellular or humoral immune re-
sponses to influenza, meningococci, and
yellow-fever vaccines have all been re-
ported and reviewed elsewhere (Hagan
et al., 2015). Such predictive signatures
have also provided novel insights into the
regulation of immunity, and some have
been pursued mechanistically in follow-
up studies (Furman et al., 2014; Ravindran
et al., 2014). This illustrates the potential of
using gene expression analyses during
immune system perturbation as a means
for generating new knowledge about the
regulation of the immune system.
Meta-analyses are analytical tech-
niques used to summarize the results of
multiple studies. As such, they hold the
potential for allowing conclusions to be
drawn from more diverse sampling popu-
lations thatbetter represent thepopulation
as a whole. The increased total number
of individuals analyzed can also increase
the statistical power of the conclusions.
Finally, meta-analyses can be particularly
useful in systems immunology and the
inference of functional relationships be-Immunity 43, Detween immune system components by al-
lowing analyses of data from diverse pop-
ulations. Meta-analyses are not trivial or
without complications and major obsta-
cles have to be overcome to realize the
potential of meta-analyses across public
datasets. Many of the obstacles are tech-
nology specific and dependent on the
experimentalmethodused for data collec-
tion. Efforts to standardize immunological
assays are ongoing (Janetzki et al., 2009),
and a public repository for immunological
data—the ImmPort database—has been
established and is being populated with
cytometry data and more (Bhattacharya
et al., 2014). Gene expression databases
such as the NCBI Gene Expression
Omnibus, GEO, and the ArrayExpress
are more mature and well-established
repositories with impressive amounts of
data available to query. For example,
the ArrayExpress currently contains
more than 1.8 million assays from more
than 60,000 experiments, an incredible
resource for those with the right know-
how to harvest its full potential through
meta-analyses (Figure 1).
In this issue of Immunity, two such
groups present their recent findings using
data from the NCBI GEO. In the first study,
Khatri and colleagues make use of an
elegant and recently described meta-
analysis approach (Khatri et al., 2013; An-
dres-Terre et al., 2015). By combining two
different methods for finding differentially
regulated genes across multiple studies,
more robust signatures can be identified.
By performing such meta-analyses in an
iterative leave-one-study-out cycle, the
authors prevent individual studies from
inadvertently dominating the resulting sig-
natures. Using this analytical pipeline, the
group studies immune responses to res-
piratory viral infections and is able to iden-
tify a signature specific to such responsescember 15, 2015 ª2015 Elsevier Inc. 1035
Figure 1. Understanding Immune Responses to Viruses and Vaccines through Analyses of Diverse Populations
With the use of clever strategies for meta-analysis of public gene expression data, a puzzle can be put together to identify shared or contrasting gene expression
signatures among diverse populations, represented by the characters in each puzzle piece. These signatures can predict important clinical outcomes and
suggest novel mechanisms of immune system regulation.
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tients. Using this signature, patients with
respiratory viral infection can be distin-
guished from healthy controls and, impor-
tantly, also from patients with bacterial
infections. This important finding made
possible through public data meta-anal-
ysis should inspire immunologists to
formulate novel, testable hypotheses
about the role of these identified genes
in regulating antiviral immune responses.
Moreover, using the same strategy, the
group also presents a smaller, 11-gene
signature specific to influenza virus
infection that is predictive of clinical
outcome as well as flu-vaccine re-
sponses. Although these 11 genes in the
flu-specific signature were differentially
expressed across age groups, gender,
and disease severity, none of the individ-
ual studies included in the meta-analysis
had been able to identify all 11 genes,
suggesting that the meta-analysis
approach provides enhanced precision
over previous published reports. Also,
the genes in this signature probably
contain important clues to the mecha-
nisms of flu-specific immune responses
in the context of both infection and
vaccination.
In the second study, Nakaya et al.
(2015) address the important issue of
whether immune responses to flu vac-
cines are similar across multiple flu sea-
sons and across diverse populations of
young and old, healthy or diseased. Flu1036 Immunity 43, December 15, 2015 ª201viruses change from one year to the
next through antigenic drift and antigenic
shift. Whether previously reported gene
signatures predictive of early humoral
vaccine responses would also be robust
enough to predict responses across
different years despite antigenic changes
was unknown. The authors perform
meta-analyses of blood gene expression
data collected across multiple flu sea-
sons and in different studies and reveal
a signature that was indeed able to pre-
dict the humoral response at day 28 after
vaccination across these multiple sea-
sons. The same signature was not pre-
dictive of the later day 180 humoral
response, suggesting that different
mechanisms and pathways are involved
in regulating the longevity of vaccine re-
sponses. These important findings sug-
gest that core mechanisms determine
the immune system’s early response to
flu vaccines—mechanisms that could
potentially be the target of a universal
influenza vaccine in the future. Another
important issue addressed by Nakaya
et al. (2015) relates to the known reduc-
tion in flu-vaccine responsiveness among
many elderly, a key target population for
this vaccine. It is important to understand
whether signatures predictive of re-
sponses are equally predictive in the
young and the elderly, and if not, whether
other signatures could better predict the
responses in the elderly and provide an
explanation to the observations that5 Elsevier Inc.some elderly individuals respond while
many others do not. The authors present
a predictive gene signature that is equally
predictive in the young, the elderly, and
also in a smaller group of patients with
type II diabetes, suggesting that vaccine
responders across these different groups
respond by similar mechanisms. This
also suggests that by exploring the
genes in this signature, one could learn
a lot more about these shared vaccine-
response mechanisms.
Together, the studies of Andres-Terre
et al. (2015) and Nakaya et al. (2015) have
used innovative ways to generate new in-
sights from public datasets that will now
have immunologists sifting through sup-
plementarygene lists in searchof novel hy-
potheses regarding the regulation of anti-
viral and flu-vaccine immune responses
for future follow-up experiments.REFERENCES
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Commensal microorganisms influence malignant progression by altering systemic inflammation. New data
from two groups (Ve´tizou et al., 2015; Sivan et al., 2015) indicate that the abundance of specific commensal
bacterial species enhances the anti-cancer activity of immune checkpoint inhibitors.Humans co-exist in a symbiotic relation-
ship with trillions of bacteria, viruses,
and fungi that populate the intestine,
skin, and upper respiratory and genitouri-
nary tracts. Technological advances have
unveiled that the normal flora of humans is
remarkably complex in that its compo-
nents outnumber human cells at a ratio
of 10:1. The intestine alone harbors up to
1,000 commensal bacterial species (Tud-
denham and Sears, 2015), mostly from
four major lineages (termed phyla): Pro-
teobacteria, Firmicutes, Actinobacteria,
and Bacteroidetes. Variations in the
composition of the bacterial flora have
been associated with metabolic changes
and obesity, as well as inflammation,
autoimmunity, and infectious diseases.
Studies with germ-free mice have shown
that forging a robust immune system
and a broad repertoire of T cell receptors
requires colonization by commensal mi-
croorganisms. The role of the microbiota
in the progression of extra-intestinal tu-mors, however, has only emerged in the
last 2 years.
Commensal bacteria have been found
to influence distal malignant evolution
by modulating systemic tumor-promoting
inflammation and, subsequently, the
magnitude of T-cell-dependent anti-tu-
mor immunity (Rutkowski et al., 2015). In
this study, tumor growth depended upon
host commensal microbes and was inde-
pendent of measurable bacterial translo-
cation. Intrinsic differences in some bac-
terial genera, such as Bacteroides, were
identified in co-housed mice that devel-
oped tumors at different growth rates in
a toll-like receptor 5 (TLR5)-dependent
manner (Rutkowski et al., 2015). How-
ever, the abundance of segmented fila-
mentous bacteria (SFBs), an obvious
target identified to drive interleukin-17
(IL-17) production and autoimmunity in
tumor-free mice (Ivanov et al., 2009;
Sano et al., 2015), was unchanged in
mice showing TLR5-dependent acceler-ated malignant progression. Therefore,
changes in the equilibrium between
commensal microbial communities (or
dysbiosis) influence the tumor growth
distally from places of bacterial coloniza-
tion. Elegant independent studies have
also demonstrated that the effectiveness
of immunotherapy against different tu-
mors also requires the presence of
commensal bacteria (Iida et al., 2013; Vi-
aud et al., 2013). However, understanding
how the repertoire of commensal mi-
crobes can be specifically manipulated
to synergize with available anti-cancer in-
terventions has remained elusive.
In a recent issue of Science, data from
two groups demonstrate how individual
bacterial species can be used to enhance
the effectiveness of immune checkpoint
inhibitors. Ve´tizou et al. (2015) and Sivan
et al. (2015) independently demonstrate
that the abundance of distinct species
fromthephylumBacteroidetesanddistinct
genera from the phylum Actinobacteria iscember 15, 2015 ª2015 Elsevier Inc. 1037
